Personalized immunosuppression after kidney transplantation

With advances in immunosuppressive therapy, there have been significant improvements in acute rejection rates and short‐term allograft survival in kidney transplant recipients. However, this success has not been translated into long‐term benefits by the same magnitude. Optimization of immunosuppress...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nephrology (Carlton, Vic.) Vic.), 2022-06, Vol.27 (6), p.475-483
Hauptverfasser:	Cheung, Chi Yuen, Tang, Sydney Chi Wai
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Clinical trials Cytochrome P-450 CYP3A - genetics Dosage Genotype Genotypes Graft rejection Graft Rejection - genetics Graft Rejection - prevention & control Humans Immunosuppression Immunosuppression Therapy - adverse effects Immunosuppressive agents Immunosuppressive Agents - adverse effects kidney transplant Kidney transplantation Kidney Transplantation - adverse effects Nephropathy Patients personalized medicine Pharmacogenetics Tacrolimus Transplants & implants
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!